Lenvatinib for the treatment of renal cell carcinoma.

MLA

Roviello, Giandomenico, et al. “Lenvatinib for the Treatment of Renal Cell Carcinoma.” Expert Opinion on Investigational Drugs, vol. 27, no. 5, May 2018, pp. 507–12. EBSCOhost, https://doi.org/10.1080/13543784.2018.1472235.

APA

Roviello, G., Corona, S. P., Bozza, G., Aieta, M., Generali, D., Rodriquenz, M. G., Mileo, A. M., Imperatori, M., Ianza, A., Conca, R., & Sobhani, N. (2018). Lenvatinib for the treatment of renal cell carcinoma. Expert Opinion on Investigational Drugs, 27(5), 507–512. https://doi.org/10.1080/13543784.2018.1472235

Chicago

Roviello, Giandomenico, Silvia Paola Corona, Giovanni Bozza, Michele Aieta, Daniele Generali, Maria Grazia Rodriquenz, Anna Maria Mileo, et al. 2018. “Lenvatinib for the Treatment of Renal Cell Carcinoma.” Expert Opinion on Investigational Drugs 27 (5): 507–12. doi:10.1080/13543784.2018.1472235.